Weekly Digest – July 2025 Weekly Digest – July 2025 14 July 2025: Oncomatryx Biopharma awarded prestigious EIC accelerator funding to advance groundbreaking ADCs Oncomatryx Biopharma has secured €2.5 million in grant funding and a €10 million equity investment from […]
Weekly Digest – July 2025 Weekly Digest – July 2025 14 July 2025: Defence’s Accum technology with ADC and radiopharmaceutical programs target cancer Defence Therapeutics is advancing its Accum-based ADC and radiopharmaceutical programs, showing superior intracellular delivery and cytotoxicity in […]
Weekly Digest – July 2025 Weekly Digest – July 2025 15 July 2025: Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova for up to $951M Sino Biopharm is acquiring LaNova Medicines for up to $951 million, consolidating its earlier minority […]
